CALCIUM ANTAGONISTS IN MANAGEMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH BRONCHIAL ASTHMA
Article is devoted to assessment the effectiveness of pharmacotherapy of arterial hypertension in patients with bronchial asthma with dihydropyridine and non-dihydropyridine calcium antagonists (Stamlo M, Altiazem RR). The study included monitoring of arterial pressure, respiratory function, vegetative status and lipid metabolism to identifying characteristics of individual reactions to various groops of calcium antagonists. It was established that the pharmacotherapy with Stamlo M has a better antihypertensive effect with a more pronounced activation of the sympathetic nervous system, in comparison with therapy with Altiazem RR, and provides a correction of certain indicators of lipid spectrum